Information about Pharmalex
My details
*
*
*

Company information

Status
Active

Enterprise number

BE0471.925.883

VAT liability
Yes
Established
17-05-2000
Last balance sheet year
2025
Company size
Medium-sized 15 FTE
Principal activity
Accounting, bookkeeping, auditing activities and tax consultancy
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Pharmalex

2025 2024 2023 2022
Profit/Loss 64,882 -63 % 174,155 -53 % 368,819 109 % 176,576
Turnover - - 1,869,958 -
Equity 1,916,472 1 % 1,897,094 -4 % 1,965,958 3 % 1,900,177
Gross margin 1,155,574 -5 % 1,215,556 -1 % 1,234,017 107 % 595,958
Employees 15 14.8 12.3

Publications from Pharmalex

Date Publication
28-02-2023 Resignations, Appointments (FR)
28-06-2022 Modification Legal Form - Goal - Resignations, Appointments - General meeting - Financial Year (FR)
22-01-2018 Capital, Shares (FR)
19-12-2013 Capital, Shares (FR)
27-05-2000 Constitution (FR)

Frequently asked questions

What is the VAT number of Pharmalex?
The VAT number of Pharmalex is BE 0471.925.883.
Wat is the PEPPOL ID of Pharmalex?
The PEPPOL ID of Pharmalex is 0208:0471925883. Log in or start a free trial to see the full overview.
When was Pharmalex founded?
Pharmalex was founded on 17-05-2000.
What is the address of Pharmalex?
The current registered office of Pharmalex is located at Rue de Mulhouse 33/B, 4020 Liège.
When was the last time Pharmalex filed their annual financial statements?
The most recent financial statements of Pharmalex were filed on 10-01-2026.
How many employees does Pharmalex have?
There are 15 FTEs working at Pharmalex according to the staff figures in the most recent financial statements.
What is the annual turnover of Pharmalex?
At the time of its most recent financial statements, Pharmalex did not publish any turnover figures. Pharmalex reported a gross margin of €1,155,574.13.